Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» mTOR inhibitors
mTOR inhibitors
Aadi axes 80% of staff after registrational Phase II trial fails
Clinical Trials Arena
Wed, 08/21/24 - 11:36 am
Aadi Biosciences
clinical trials
layoffs
mTOR inhibitors
nab-sirolimus
Anti-rejection drug rapamycin shows promise in liver cancer
Fierce Biotech
Fri, 02/1/19 - 10:46 pm
liver cancer
mTOR inhibitors
rapamycin
AZ drops midstage cancer drug vistusertib
Fierce Biotech
Thu, 11/8/18 - 12:17 pm
AstraZeneca
mTOR inhibitors
vistusertib
Afinitor data could be 'game-changer' in breast cancer
Fierce Pharma
Mon, 09/26/11 - 12:05 pm
Afinitor
breast cancer
mTOR inhibitors
Pfizer
Aromasin
US FDA approves trial of Pathway Therapeutics cancer drug
pharmabiz
Sat, 05/28/11 - 02:05 pm
Pathway Therapeutics
PWT33597
mTOR inhibitors
PI3K
oncology
cancer
Synta's Lead Program Gains Momentum
Seeking Alpha
Sun, 12/5/10 - 12:28 pm
Synta
mTOR inhibitors
STA-9090
cancer
Ariad Gets Good News on Its Endometrial Cancer Drug
Seeking Alpha
Tue, 11/23/10 - 09:27 am
endometrial cancer
Ariad Pharmaceuticals
Merck
mTOR inhibitors
ridaforolimus
Trius, Ariad Show Interesting Pipeline Potential
Seeking Alpha
Sun, 10/24/10 - 01:33 pm
Trius Therapeutics
Ariad Pharmaceuticals
rapamycin
mTOR inhibitors